Long-term clinical outcome after stent implantation in saphenous vein grafts

Catheterization Laboratory, Thoraxcenter, Rotterdam, The Netherlands.

OBJECTIVES: We sought to determine the role of stent implantation in vein grafts by evaluating the long-term clinical outcome and estimated event-free survival at 5 years in 62 patients and by comparing our data with those of other treatment modalities previously reported. BACKGROUND: Patients with recurrent angina after coronary artery bypass graft surgery pose a problem. Stent implantation has been advocated in an effort to avoid repeat operation and to address the limitations of balloon angioplasty. METHODS: Patients undergoing stenting of a vein graft were entered into a dedicated data base. They were screened for death, infarction, bypass surgery and repeat angioplasty. Procedure-related events were included in the follow-up analysis. Survival and event-free survival curves were constructed by the Kaplan Meier method. RESULTS: A total of 93 stents (84 Wallstent and 9 Palmaz-Shatz) were implanted in 62 patients. During the in-hospital period seven patients (11%) sustained a major cardiac event: two deaths (3%), two myocardial infarctions (3%) and three urgent bypass surgeries (5%). The clinical success rate, therefore, was 89%. During the follow-up period (median 2.5 years, range 0 to 5.9), another five patients (8%) died, 14 (23%) sustained a myocardial infarction, 12 (20%) underwent bypass surgery, and 14 (23%) underwent angioplasty. The estimated 5-year survival and event-free survival rates (free from infarction, repeat surgery and repeat angioplasty) were (mean +/- SD) 83 +/- 5% (95% confidence interval [CI] 73% to 93%) and 30 +/- 7% (95% CI 16% to 44%), respectively. CONCLUSIONS: The in-hospital outcome of patients who underwent stent implantation in a vein graft is acceptable, but the long-term clinical outcome is poor. It is unlikely that mechanical intervention alone will provide a satisfactory or definite answer for the patient with graft sclerosis over the long term.

This article has been cited by other articles:

				D. Bansal, R. Sachdeva, and J. L. Mehta Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents. J. Am. Coll. Cardiol., March 4, 2008; 51(9): 970 - 971. [Full Text] [PDF]

				R. H. Mehta, E. Honeycutt, E. D. Peterson, C. B. Granger, A. R. Halabi, L. K. Shaw, P. K. Smith, R. M. Califf, R. A. Harrington, and M. H. Sketch Jr Impact of Internal Mammary Artery Conduit on Long-term Outcomes After Percutaneous Intervention of Saphenous Vein Graft Circulation, July 4, 2006; 114(1_suppl): I-396 - I-401. [Abstract] [Full Text] [PDF]

				G. Stankovic, A. Colombo, P. Presbitero, F. van den Branden, L. Inglese, C. Cernigliaro, L. Niccoli, A. L. Bartorelli, P. Rubartelli, N. Reifart, et al. Randomized Evaluation of Polytetrafluoroethylene-Covered Stent in Saphenous Vein Grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial Circulation, July 8, 2003; 108(1): 37 - 42. [Abstract] [Full Text] [PDF]

				P.J. de Feyter Percutaneous Treatment of Saphenous Vein Bypass Graft Obstructions: A Continuing Obstinate Problem Circulation, May 13, 2003; 107(18): 2284 - 2286. [Full Text] [PDF]

				E. C. Keeley, C. A. Velez, W. W. O'Neill, and R. D. Safian Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts J. Am. Coll. Cardiol., September 1, 2001; 38(3): 659 - 665. [Abstract] [Full Text] [PDF]

				S. C. Smith Jr, J. T. Dove, A. K. Jacobs, J. Ward Kennedy, D. Kereiakes, M. J. Kern, R. E. Kuntz, J. J. Popma, H. V. Schaff, D. O. Williams, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2239 - 2239. [Full Text] [PDF]

				P.J. De Feyter and D. Foley Coronary stent implantation: a panacea for the interventional cardiologist? Eur. Heart J., November 1, 2000; 21(21): 1719 - 1726. [PDF]

				P. A. Ribeiro, K. Scavetta, C. Oh, M. Al-Zaibag, K. R. Jutzy, R. Caldron, and R. J. Marsa Long-term Clinical Results After Stent Implantation in Old Obstructed Saphenous Vein Grafts Chest, September 1, 2000; 118(3): 750 - 755. [Abstract] [Full Text] [PDF]

				R. Choussat, A. J. R. Black, I. Bossi, T. Joseph, J. Fajadet, and J. Marco Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents J. Am. Coll. Cardiol., August 1, 2000; 36(2): 387 - 394. [Abstract] [Full Text] [PDF]

				B. Bhargava, R. Kornowski, R. Mehran, K. M. Kent, M. K. Hong, A. J. Lansky, R. Waksman, A. D. Pichard, L. F. Satler, and M. B. Leon Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting J. Am. Coll. Cardiol., February 1, 2000; 35(2): 389 - 397. [Abstract] [Full Text] [PDF]

				J. G. Webb, R. G. Carere, R. Virmani, D. Baim, P. S. Teirstein, P. Whitlow, C. McQueen, F. D. Kolodgie, E. Buller, A. Dodek, et al. Retrieval and analysis of particulate debris after saphenous vein graft intervention J. Am. Coll. Cardiol., August 1, 1999; 34(2): 468 - 475. [Abstract] [Full Text] [PDF]

				K K HAASE, A BAUMBACH, and K R KARSCH Stents are used too often Heart, June 1, 1998; 79(6): 541 - 542. [Full Text]

				J. G. Motwani and E. J. Topol Aortocoronary Saphenous Vein Graft Disease : Pathogenesis, Predisposition, and Prevention Circulation, March 10, 1998; 97(9): 916 - 931. [Abstract] [Full Text] [PDF]